Physician profile
Ryan W Black
NPI 1932452091
$603.43
in general payments reported to CMS, 2019-2025
13 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.00 · 2023: $120 · 2024: $201 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $154.59 | 2023-2025 | Adbry |
| Regeneron Healthcare Solutions, INC. | $101.76 | 2022-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $73.90 | 2023-2025 | |
| Lilly USA, LLC | $64.55 | 2023-2025 | Ebglyss, Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $35.68 | 2024 | |
| Galderma Laboratories, L.P. | $32.99 | 2024 | |
| Abbvie INC. | $31.28 | 2023-2024 | |
| Fresenius Kabi USA, LLC | $23.13 | 2024 | Idacio |
| Janssen Biotech, INC. | $20.39 | 2023 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $17.09 | 2025 | Sotyktu |
| Ucb, INC. | $16.89 | 2024 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $16.68 | 2025 | Zoryve |
| Genzyme Corporation | $14.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.